Breaking the barriers to global gene delivery

article

Breaking the barriers to global gene delivery is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/NBT0305-305
P698PubMed publication ID15765082

P2093author name stringMatthew D Weitzman
Patricia A Thistlethwaite
P2860cites workNovel adeno-associated viruses from rhesus monkeys as vectors for human gene therapyQ24535690
Systemic delivery of genes to striated muscles using adeno-associated viral vectors.Q34347199
Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vectorQ35872651
Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificityQ39686097
Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector.Q41722852
Stable restoration of the sarcoglycan complex in dystrophic muscle perfused with histamine and a recombinant adeno-associated viral vectorQ43783192
Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heartQ45507049
Efficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6.Q45571369
Differential myocardial gene delivery by recombinant serotype-specific adeno-associated viral vectorsQ45877527
Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene deliveryQ45888008
P433issue3
P407language of work or nameEnglishQ1860
P304page(s)305-306
P577publication date2005-03-01
P1433published inNature BiotechnologyQ1893837
P1476titleBreaking the barriers to global gene delivery
P478volume23

Reverse relations

cites work (P2860)
Q37766138Advances in gene-based therapy for heart failure
Q64977765Circumventing cellular immunity by miR142-mediated regulation sufficiently supports rAAV-delivered OVA expression without activating humoral immunity.